Sunday, 27 November, 2022
TopicPharmaceutical

Topic: pharmaceutical

Cough syrups made by Delhi-based Maiden Pharma may be tied to 66 deaths in Gambia, says WHO

In July, alarm was raised in Gambia after several children began falling ill with kidney problems. WHO has issued an alert asking regulators to remove the company's goods from the market.

CBI chargesheet in Biocon case raises questions about how India manages drug trials

CBI action against CDSCO official accused of corruption draws attention to India’s drug regulatory framework & changes brought to expedite access to latest drugs & pharmaceutical products.

Bajaj Healthcare is first private entity to enter highly-regulated opium processing sector 

Although India is one of the few countries that permit opium cultivation, its processing has so far been highly centralised.

India banks on Hyderabad’s ‘Pharma City’ to break China’s stranglehold over drug supplies

India’s $42 billion drug manufacturing industry relies intensely on China, which supplies almost 70% of the active pharmaceutical ingredients that go into making medicines.

Western companies should supply essential medicines to Ukraine, not pull out entirely

Putin may not be swayed by the suffering of people. Any interruption of supply of medicines can create human misery without any gain.

Pandemic can’t be allowed to devastate nations because of sophisticated, one-sided WTO rules

For President Joe Biden to take a stand against pharmaceutical companies is no small matter. His presidential campaign was the near sole beneficiary of pharma largesse in 2020.

Antidepressant Escitalopram ‘linked to suicidal thoughts’, must carry strongest warning — govt

Citing FDA warning, India's drug regulator starts examining warnings, prescribing information and package inserts given by Indian drugmakers manufacturing Escitalopram.

J&J’s new flu drug flop shows how difficult it is to fight viruses

Johnson & Johnson stopped developing the drug pimodivir in the final stage of testing it for patients with influenza A, the most common cause of flu, after a study indicated it won't work.

How a Chinese firm jumped to the front of the global Covid vaccine race

China’s pharma industry has been dogged by safety incidents & quality scandals. But in recent years, hundreds of Chinese scientists trained in the West have come home.

Cheers to health! This was a decade of drug breakthroughs – from Cancer to Hepatitis C

Multiple new categories of medicines have moved from dreams & lab benches into the market and people’s lives. Now they need to become affordable.

On Camera

YourTurn

A general view of the opening ceremony of the G20 finance ministers and central bank governors meeting in Jakarta, Indonesia, February 17, 2022. Mast Irham/Pool via REUTERS

G20 presidency is India’s chance to fix power imbalances in artificial intelligence adoption

Without considering AI challenges across the world, equitably reaping its benefits will remain inadequate, leading to a more unequal and divisive future.
Representational image | Wiki Commons

How India-Australia FTA is set to boost trade that’s already at a record high

While the bulk of the trade between India and Australia is so far in the energy sector, the FTA is expected to broaden this to include other goods and services.

Defence

Illustration: Soham Sen | The Print

Modi govt moves with Arunachal Frontier Highway, among India’s ‘toughest’ projects yet, China in mind

The 2,000 km-long highway will be of strategic importance to military. Same equipment used on other side of LAC being deployed to carry out work on tough terrain, say officials.

A Gujarat gamble: A likely reason Rahul is not giving Modi a fight this assembly election

I'd rather not buy idea that Rahul's holding his fire until 2024. More likely, Congress believes Karnataka offers best chance of winning a Gujarat-sized state if Gujarat is too challenging.